Related Experiment Video

Updated: Sep 27, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

[Mechanism of multidrug resistance of ovarian cancer]

Magdalena Miedzińska-Maciejewska1, Gabriel Wcisło

  • 1Klinika Onkologii CSK WAM-Oddział Kobiecy 00-909 Warszawa, ul. Szaserów 128. magdam@kkcmkp.pl

Przeglad Lekarski
|March 14, 2003
PubMed

Insights

Ovarian cancer survival remains low due to late diagnosis and treatment resistance. Understanding drug resistance mechanisms is crucial for improving patient outcomes in ovarian cancer therapy.

Area of Science:

  • Gynecologic Oncology
  • Cancer Biology
  • Pharmacology

Context:

  • Ovarian cancer is a frequent malignancy in women with a poor 5-year survival rate (20-30%).
  • Late diagnosis and acquired chemoresistance limit treatment efficacy.
  • Current surgical and chemotherapeutic advances have not significantly improved survival rates.

Purpose:

  • To review the fundamental mechanisms of drug resistance in ovarian cancer.
  • To discuss the clinical significance of these resistance mechanisms.

Summary:

  • Ovarian cancer treatment often fails due to initial late detection and subsequent development of chemoresistance.
  • Despite initial treatment responses, most patients experience relapse with tumors resistant to standard chemotherapy.
  • This review details the basic molecular mechanisms underlying drug resistance in ovarian cancer.

Impact:

  • Provides insights into why ovarian cancer treatments fail.
  • Highlights the need for novel therapeutic strategies targeting drug resistance.
  • Aims to improve clinical management and survival for ovarian cancer patients.

More Related Videos

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...